NEWS
JOHNSON & JOHNSON HIGHLIGHTS COMMITMENT TO TRANSFORM TREATMENT OF RETINAL DISEASES AT ARVO 2024
Johnson & Johnson spotlighted its EYE-RD Global Registry at the Association for Research in Vision and Ophthalmology ( ARVO ) 2024 Annual Meeting held in Seattle in May .
The first-of-its-kind observational , non-interventional global IRD registry created to make clinical information on IRDs more accessible to patients , providers , payers and researchers . The registry served as a centralised repository of longitudinal data collected on genetically tested patients who were diagnosed or had a suspected diagnosis of IRDs such as X-linked retinitis pigmentosa , a rare IRD estimated to impact one in 40,000 people globally . The registry had the potential to bridge the knowledge gap in IRDs through the collection of real-world data by collating more holistic insights about disease progression and patient experiences .
" At Johnson & Johnson , we are committed to preserving vision , harnessing the best science to find solutions for those living with blinding retinal diseases ," said Hideo Makimura , MD , PhD , Vice President and Global Head , Specialty Ophthalmology Research and Development , Johnson & Johnson Innovative Medicine . " The data at ARVO 2024 showcase our commitment to bringing innovative new therapies that preserve and restore vision for patients worldwide ."
The company also hosted two oral presentations , one evaluating the role of automatic Deep Learning based algorithms to measure precursors of geographic atrophy ( GA ), a late-stage and severe form of age-related macular degeneration ( AMD ).
NEW GUIDELINE PROVIDES RECOMMENDATIONS FOR INTERPROFESSIONAL TEAMS IN DIGITAL HEALTH ENVIRONMENTS
At a time when digital environments are changing care delivery , the Registered Nurses ' Association of Ontario ( RNAO ) has released a new best practice guideline ( BPG ) to support nurses and interprofessional health teams in their practice . Titled Clinical Practice in a Digital Health Environment , this BPG features evidencebased recommendations to support care across settings and sectors to improve people ' s health outcomes and equity . to guide the implementation of the recommendations and evaluate their impact within organisations . " We look forward to supporting the work of all health professionals , teams , organisations and systems as they apply this novel BPG into clinical practice to provide safe , quality care using advanced technology , such as predictive analytics ," added Grinspun .
The BPG ' s interprofessional expert panel was co-chaired by the late Dr Vanessa Burkoski , former Chief Nursing Executive and Chief of People Strategy at Humber River Health , and Maureen Charlebois , Chief Nursing and Clinical Officer at Bayshore HealthCare . This guideline is dedicated to Burkoski , who passed away in August 2023 .
" Nurses and other health providers are increasingly using digital health technologies powered by Artificial Intelligence and Deep Machine Learning , in practice ; and this BPG provides a roadmap to ensure high quality and equitable care regardless of setting ," said Dr Doris Grinspun , RNAO CEO and Founder of the world-renowned BPG programme . The guideline also outlines the many resources available
10 www . intelligenthealth . tech